269 related articles for article (PubMed ID: 31620986)
1. Thalassemia: Common Clinical Queries in Management.
Lal A; Bansal D
Indian J Pediatr; 2020 Jan; 87(1):75-81. PubMed ID: 31620986
[TBL] [Abstract][Full Text] [Related]
2. Thalassemia intermedia today: should patients regularly receive transfusions?
Aessopos A; Kati M; Meletis J
Transfusion; 2007 May; 47(5):792-800. PubMed ID: 17465943
[TBL] [Abstract][Full Text] [Related]
3. Morbidities in non-transfusion-dependent thalassemia.
Saliba AN; Taher AT
Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941
[TBL] [Abstract][Full Text] [Related]
4. Current recommendations for chelation for transfusion-dependent thalassemia.
Kwiatkowski JL
Ann N Y Acad Sci; 2016 Mar; 1368(1):107-14. PubMed ID: 27186943
[TBL] [Abstract][Full Text] [Related]
5. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
6. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.
Kontoghiorghe CN; Kontoghiorghes GJ
Drug Des Devel Ther; 2016; 10():465-81. PubMed ID: 26893541
[TBL] [Abstract][Full Text] [Related]
8. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
Taher AT; Temraz S; Cappellini MD
Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
[TBL] [Abstract][Full Text] [Related]
9. Non-Transfusion-Dependent Thalassemia: A Panoramic Review.
Shash H
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295656
[TBL] [Abstract][Full Text] [Related]
10. Challenges of blood transfusions in β-thalassemia.
Shah FT; Sayani F; Trompeter S; Drasar E; Piga A
Blood Rev; 2019 Sep; 37():100588. PubMed ID: 31324412
[TBL] [Abstract][Full Text] [Related]
11. Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.
Sleiman J; Tarhini A; Bou-Fakhredin R; Saliba AN; Cappellini MD; Taher AT
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316681
[TBL] [Abstract][Full Text] [Related]
12. Thalassemia Minor and Major: Current Management.
Choudhry VP
Indian J Pediatr; 2017 Aug; 84(8):607-611. PubMed ID: 28435994
[TBL] [Abstract][Full Text] [Related]
13. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
Bradai M; Pissard S; Abad MT; Dechartres A; Ribeil JA; Landais P; de Montalembert M
Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
[TBL] [Abstract][Full Text] [Related]
14. Common queries in thalassemia care.
Panigrahi I; Marwaha RK
Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
[TBL] [Abstract][Full Text] [Related]
15. When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.
Taher AT; Radwan A; Viprakasit V
Vox Sang; 2015 Jan; 108(1):1-10. PubMed ID: 25286743
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia.
Chuansumrit A; Sirachainan N; Kitpoka P; Kadegasem P; Songdej D; Sasanakul W; Wongwerawattanakoon P
Hemoglobin; 2019; 43(4-5):264-272. PubMed ID: 31760834
[TBL] [Abstract][Full Text] [Related]
17. Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
Ricchi P; Meloni A; Costantini S; Spasiano A; Di Matola T; Pepe A; Cinque P; Filosa A
Ann Hematol; 2017 Sep; 96(9):1541-1546. PubMed ID: 28707012
[TBL] [Abstract][Full Text] [Related]
18. Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition.
Viprakasit V; Tyan P; Rodmai S; Taher AT
Orphanet J Rare Dis; 2014 Sep; 9():131. PubMed ID: 25265971
[TBL] [Abstract][Full Text] [Related]
19. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
Vichinsky E
Curr Med Res Opin; 2016; 32(1):191-204. PubMed ID: 26479125
[TBL] [Abstract][Full Text] [Related]
20. Report on patients with non transfusion-dependent β-thalassemia major being treated with hydroxyurea attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013.
Kosaryan M; Karami H; Zafari M; Yaghobi N
Hemoglobin; 2014; 38(2):115-8. PubMed ID: 24471558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
